Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Segments and Growth by 2031

The small intestinal bacterial overgrowth (SIBO) diagnostics market size is projected to reach US$ 266.81 million by 2031 from US$ 155.60 million in 2023. The market is expected to register a CAGR of 4.8% during 2023–2031. Next-generation sequencing technologies to diagnose SIBO is likely to remain key trend in the market.

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis

Increasing incidence of SIBO, rising demand for non-invasive diagnostics tests, and technological advancements in diagnostic tests are fueling the growth of the small intestinal bacterial overgrowth (SIBO) diagnostics market. In addition, the growing focus on gut health and digestive health, expansion of healthcare infrastructure, and growing awareness and education about SIBO among healthcare professionals and patients are driving the growth of the small intestinal bacterial overgrowth (SIBO) diagnostics market

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Overview

Geographically, Asia Pacific is expected to register highest CAGR in the forecast period 2023-2031. India is among the fastest-developing nations in the world and is among the top leading countries of Asia Pacific. India is the fastest developing country in the Asia Pacific region. It has well-established companies operating in the biotechnology and medical device industry. Also, the a rising number of startups that are introducing laboratory equipment that utilizes the latest technologies. Whereas, rising cases of diarrhea, SIBO, and gastrointestinal diseases widen growth opportunities for India's small intestinal bacterial overgrowth (SIBO) diagnostics market. Similarly, the increasing number of hospitals and diagnostics laboratories across the country is likely to increase demand for modernized diagnostic instruments and equipment, offering a favorable environment for India small intestinal bacterial overgrowth diagnostics market during the forecast period.

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market: Strategic Insights

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Drivers and Opportunities

Increasing Prevalence of Irritable Bowel Syndrome (IBS) to Favor Market

Irritable bowel syndrome (IBS) is the commonly diagnosed gastrointestinal disorder with abdominal pain and altered bowel habits resulting with associated symptoms such as bloating, malabsorption, and systemic symptoms. Crohn's disease and ulcerative colitis are types of IBS. It causes swelling in the digestive tract, which can cause abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. According to MedlinePlus, Crohn's disease is most prevalent in Western Europe and North America, with a prevalence rate of 100 to 300 per 100,000 people. According to the Medscape data, the incidence of ulcerative colitis in the US is 10.4–12 cases per 100,000 people, and the prevalence rate is 35–100 cases per 100,000 people. As compared to Crohn disease, ulcerative colitis is three times more common. IBD is thought to be a result of a multitude of environmental and bacterial interactions with immune-mediated factors in a genetically susceptible host. The increasing prevalence of IBS across the world is due to the changing lifestyle and dietary habits. Small intestinal bacterial overgrowth (SIBO) is widely associated with the IBS. Thus increasing prevalence of IBS fuelis the growth of the SIBO diagnostics market as it increases the prevalence of SIBO.

Development of Capsule Technology act as an Opportunity for Market Growth

The growing technological developments in the field of medical devices have offered various innovative products to diagnose several complex human health conditions. Thus, to diagnose SIBO, an innovative orally ingested capsule technology is in the developmental process. It is designed in a way to measure in vivo hydrogen and carbon-di-oxide after ingestion of a carbohydrate meal and provide a technologically updated alternative to the current breath hydrogen test. It is expected that the capsule technology will help in diagnosing samples of small bowel bacteria. Thus, the introduction of capsule technology is likely to emerge in the coming future and contribute to direct and accurate evaluation of SIBO and offer vital growth opportunities for the market’s growth.

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report Segmentation Analysis

Key segments that contributed to the derivation of the small intestinal bacterial overgrowth (SIBO) diagnostics market analysis are product, and end user.

• Based on product, the small intestinal bacterial overgrowth (SIBO) diagnostics market is divided into breath testing, small intestine aspirate and fluid culture test, blood test, and others. The types of breath tests are further sub-categorized as 14C xylose breath test, hydrogen breath test, 14C glycocholic acid breath, and others. The breath testing segment held the largest market share in 2023.
• Based on type, the small intestinal bacterial overgrowth (SIBO) diagnostics market is divided into hydrogen-predominant SIBO, methane-predominant SIBO, and recurrent SIBO. The hydrogen-predominant SIBO segment held the largest market share in 2023.

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Share Analysis by Geography

The geographic scope of the small intestinal bacterial overgrowth (SIBO) diagnostics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market. North America is the largest market in the forecast period due to the increasing incidence of SIBO in the countries, growing government support, and increasing number of product introductions. In addition, rising demand for advanced diagnostic infrastructure is also likely to accelerate market growth during the forecast period. The US is the largest and fastest-growing country for the small intestinal bacterial overgrowth (SIBO) diagnostics market in the global market. The market's growth is primarily attributed to the increasing prevalence of conditions such as immunodeficiency syndromes and pancreatic exocrine insufficiency amongst others. Growing prevalence of risk factors associated with the SIBO are also expected to drive the prevalence of the condition, which will eventually offer favorable environment for growth of US small intestinal bacterial overgrowth diagnostics market

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Regional Insights

The regional trends and factors influencing the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report Scope

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market News and Recent Developments

The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the small intestinal bacterial overgrowth (SIBO) diagnostics market are listed below:

• Owlstone Medical launched  OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care (PoC) devices and support resources for a range of conditions. Initially focused on digestive disease, OMED Health will help individuals with gut health issues have an improved quality of life by enabling better, and faster, understanding and management of their conditions. (Source: Owlstone Medical, Press Release, April 2023)

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report Coverage and Deliverables

The “Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Small intestinal bacterial overgrowth (SIBO) diagnostics market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Small intestinal bacterial overgrowth (SIBO) diagnostics market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Small intestinal bacterial overgrowth (SIBO) diagnostics market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the small intestinal bacterial overgrowth (SIBO) diagnostics market
• Detailed company profiles